• 
• http://www.nature.com/tpj
• Editor: Julio Licinio, MD
• Volume 8: 6 issues per year
• ISSN: 1470-269X
• EISSN: 1473-1150
• Impact factor : 4.968*
• Impact ranking: 20/132 in Genetics & Heredity; 16/205 in Pharmacology & Pharmacy*
• Date Established: 2001
• Published on behalf of: International Society of Pharmacogenomics

Aims and Scope:

The Pharmacogenomics Journal is dedicated to the publication of original research on pharmacogenomics and its clinical applications.

Topics covered include:

• Identification of novel genomic targets for drug development
• Clinical applications of genomic science
• Potential benefits of pharmacogenomics
• Effects of genetic variability on drug toxicity and efficacy
• Pharmacokinetic variation and drug toxicity
• Pharmacodynamic variation and drug efficacy
• The integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics.

Readership:

Geneticists, molecular biologists, clinical and molecular pharmacologists, as well as those working in biotechnology, drug discovery and drug development.

The Pharmacogenomics Journal provides:

• Original Articles - high-quality reports whose conclusions represent a substantial advance in the understanding of important problems in the field.
• Review Articles - top researchers survey recent developments in topical areas of scientific research or on occasion, more wide-ranging subjects.
• News and Commentary - inform readers about new scientific advances, as reported either in recently published papers or at scientific meetings.
• Perspectives - provide an update on developments in fast-moving areas of interest.
• Ethical, Economics, Legal and Social (EELS) - present well-argued, thought-provoking analysis of issues and considerations involved in both basic research and in practice.
• Clinical Implications - either hypothetical or based on current clinical trials and encourage the transition from basic research to clinical practice by presenting a diagnostic or treatment challenge.

What makes The Pharmacogenomics Journal stand apart from other resources?

• High Quality Research - the journal provides highly cited original research in the field of genetics & heredity and pharamacology & pharmacy.
• Accessibility to a Broad Readership - articles published in The Pharmacogenomics Journal are accompanied by supplementary information in the form of text, figures, tables, or images, giving greater insight into primary research.
• Advanced User Functionality - the clean design of The Pharmacogenomics Journal facilitates easy navigation and retrieval of information for users, including those using assistive technology.
• Unique Online Features - selected articles are published online in advance of appearing in the print version, providing immediate access to the latest research.

Online features and site license access:

• Online archive available back to January 2001.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period. Archive content is freely available after five years.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Medline (PubMed), BIOSIS, Biotechnology Abstracts, Cambridge Scientific Abstracts, Chemical Abstracts Service and EMBASE.

*2007 Journal Citation Report (Thomson Reuters, 2008)